Legal & General Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-216
Closed -$5.68K – 3458
2026
Q1
$5.68K Sell
216
-38
-15% -$4.78K ﹤0.01% 3269
2025
Q4
$62.9K Sell
254
-7
-3% -$1.6K ﹤0.01% 2686
2025
Q3
$54.8K Sell
261
-3
-1% -$529 ﹤0.01% 2713
2025
Q2
$26K Buy
+264
New +$23K ﹤0.01% 2897
2023
Q2
– Sell
-93
Closed -$9.39K – 3448
2023
Q1
$9.39K Sell
93
-164
-64% -$25.1K ﹤0.01% 3216
2022
Q4
$44.6K Sell
257
-5
-2% -$3.29K ﹤0.01% 2966
2022
Q3
$251K Buy
262
+38
+17% +$37.7K ﹤0.01% 2541
2022
Q2
$150K Sell
224
-1
-0.4% -$620 ﹤0.01% 2738
2022
Q1
$156K Buy
225
+6
+3% +$4.63K ﹤0.01% 2751
2021
Q4
$199K Sell
219
-4
-2% -$3.8K ﹤0.01% 2727
2021
Q3
$225K Buy
223
+125
+128% +$92.1K ﹤0.01% 2646
2021
Q2
$63K Sell
98
-8
-8% -$5.55K ﹤0.01% 2882
2021
Q1
$79K Sell
106
-2
-2% -$1.61K ﹤0.01% 2681
2020
Q4
$84K Hold
108
– – ﹤0.01% 2633
2020
Q3
$107K Sell
108
-19
-15% -$20.2K ﹤0.01% 2467
2020
Q2
$132K Buy
127
+38
+43% +$38.2K ﹤0.01% 2455
2020
Q1
$72K Sell
89
-24
-21% -$25.1K ﹤0.01% 2497
2019
Q4
$141K Buy
113
+11
+11% +$17.7K ﹤0.01% 2489
2019
Q3
$137K Buy
102
+48
+89% +$76.4K ﹤0.01% 2437
2019
Q2
$96K Buy
54
+32
+145% +$49K ﹤0.01% 2547
2019
Q1
$38K Buy
+22
New +$36.7K ﹤0.01% 2815

Other funds holding GOSS

Legal & General Group's GOSS Position: Q2 2026 in Review

Legal & General Group sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 216 shares — an estimated $5.68K sold.

Legal & General Group first reported a position in GOSS in Q1 2019 and held it in 21 quarters. The position peaked at $251K in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Legal & General Group reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 216 Gossamer Bio shares in Q2 2026, an estimated $5.68K.
  • Legal & General Group first reported a position in Gossamer Bio in Q1 2019 and held it in 21 quarters.
  • Legal & General Group's Gossamer Bio position peaked at $251K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.